Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NUVB stock hub

Nuvation Bio Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NUVBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

NUVB

In the news

Latest news · NUVB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-39.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-19.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NUVB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001811063
Company name	Nuvation Bio Inc.
Country	United States
Country code	US
Cusip	67080N101
Employees	307
Employees Change	34%
Employees Change Percent	12.45
Enterprise value	$1.4B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US67080N1019
Last refreshed	2026-05-10
Market cap	$1.7B
Market cap category	Small-Cap
Price	$4.79
Price currency	USD
Rev Per Employee	465,947.88x
Sector	Healthcare
Sic	2834
Symbol	NUVB
Website	https://www.nuvationbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.75%
EV Sales Forward	5.94x
EV/Sales	9.45x
FCF yield	-7.56%
P/B ratio	5.21x
P/S ratio	11.66x
PS Forward	7.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-104.99%
EBITDA Margin	-103.61%
Gross margin	90.78%
Gross Profit	$129.9M
Gross Profit Growth	7,174.57%
Gross Profit Growth Q	7,701.72%
Net Income	$-146M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-102.06%
Profit Margin	-102.06%
Profit Per Employee	$-475,550
ROA	-17.02
Roa5y	-14.53
ROCE	-28.3
ROE	-39.51
Roe5y	-40.89
ROIC	-19.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	134.94%
Cagr3y	42.07%
Cagr5y	-16.14%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	1,205.52x
Revenue Growth Q	2,598.7x
Revenue Growth Quarters	4x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.26
Assets	$610.2M
Cash	$533.7M
Current Assets	$591.5M
Current Liabilities	$79.5M
Debt	$217M
Debt Equity	$0.68
Equity	$319.6M
Interest Coverage	-7.38
Liabilities	$290.7M
Long Term Assets	$18.7M
Long Term Liabilities	$211.2M
Net Cash	$316.7M
Net Cash By Market Cap	$18.99
Net Cash Growth	-29.65%
Net Debt Equity	$-0.99
Tangible Book Value	$308.8M
Tangible Book Value Per Share	$0.89
WACC	11.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.44
Inventory Turnover	1.66
Net Working Capital	$-6.2M
Quick ratio	7.04
Working Capital	$512M
Working Capital Turnover	$0.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	134.8%
200-day SMA	5.01
3Y total return	186.83%
50-day SMA	4.64
50-day SMA vs 200-day SMA	50under200
5Y total return	-58.53%
All Time High	15.23
All Time High Change	-68.55%
All Time High Date	2021-05-26
All Time Low	0.95
All Time Low Change	404.21%
All Time Low Date	2023-10-31
ATR	0.32
Beta	1.52
Beta1y	1.59
Beta2y	1.72
Ch YTD	-46.54
High	4.91
High52	9.75
High52 Date	2025-12-22
High52ch	-50.87%
Low	4.7
Low52	1.57
Low52 Date	2025-06-16
Low52ch	205.1%
Ma50ch	3.26%
Premarket Change Percent	1.25
Premarket Price	$4.87
Premarket Volume	8,932
Price vs 200-day SMA	-4.47%
RSI	51.73
RSI Monthly	53.19
RSI Weekly	46.9
Sharpe ratio	1.32x
Sortino ratio	2.32
Total Return	-15.09%
Tr YTD	-46.54
Tr1m	6.21%
Tr1w	6.68%
Tr3m	-15.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$11
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.06
Earnings Revenue Estimate	68,432,176x
Earnings Revenue Estimate Growth	2,118.94x
Operating Income	$-150.2M
Operating margin	-105
Price target	$12.25
Price Target Change	$156
Price Target Change Top	$130

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	237,618,661%
Float Percent	68.24%
Net Borrowing	197,380,000
Shares Insiders	24.3%
Shares Institutions	53.43%
Shares Out	348,201,971
Shares Qo Q	0.87%
Shares Yo Y	15.09%
Short Float	21.17%
Short Ratio	15.77
Short Shares	14.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-163.1M
Average Volume	4,177,983.05x
Bv Per Share	0.92
CAPEX	$-330,000
Ch1m	6.21
Ch1w	6.68
Ch1y	134.8
Ch3m	-15.96
Ch3y	186.8
Ch5y	-58.53
Ch6m	1.27
Change	-0.42%
Change From Open	-0.62
Close	4.81
Days Gap	0.21
Depreciation Amortization	1,965,000
Dollar Volume	13,979,231.8
Earnings Date	2026-05-04
Earnings Time	amc
EBIT	$-150.2M
EBITDA	$-148.2M
EPS	$-0.42
F Score	3
FCF	$-126.1M
FCF EV Yield	-9.33x
FCF Per Share	$-0.36
Financing CF	202,031,000
Fiscal Year End	December
Founded	2,018
Investing CF	1,702,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	5.71
Ma150ch	-16.1%
Ma20	4.79
Ma20ch	-0.02%
Net CF	77,414,000
Next Earnings Date	2026-08-06
Open	4.82
Optionable	Yes
Position In Range	42.86
Post Close	4.79
Postmarket Change Percent	0.21
Postmarket Price	$4.8
Ppne	4,133,000
Pre Close	4.81
Price Date	2026-05-08
Ptbv Ratio	5.4
Relative Volume	0.7x
Revenue	143,046,000x
SBC By Revenue	25.92x
Share Based Comp	37,073,000
Tr6m	1.27%
Us State	New York
Volume	2,918,420
Z Score	0.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NUVB pay a dividend?

Capital-return profile for this ticker.

Performance

NUVB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NUVB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+53.4%

Float: +68.2% of shares outstanding

Insider ownership

+24.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NUVB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.7

Neutral momentum band

Price vs 200-day MA

-4.5%

50/200-day relationship not available

Beta (5Y)

1.52

More volatile than the market

Sharpe ratio

1.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NUVB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NUVB stock rating?

Nuvation Bio Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NUVB analysis?

The full report lives at /stocks/NUVB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NUVB?

The latest report frames NUVB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NUVB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.